[Clinical evaluation of sultamicillin fine granules in lower respiratory tract infection]. 1988

M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
Department of Internal Medicine, Ohmuta National Hospital.

Sultamicillin (SBTPC) fine granules were given to 15 patients with respiratory tract infections at a dose of 375 mg 3 times a day. The results were excellent in 4 patients, good in 8, fair in 1 and poor in 2 with an efficacy rate of 80% which is comparable to that of SBTPC tablet (Unasyn tablet). One patient complained of difficulty in swallowing the drug probably due to its fine granular nature. No side effects nor abnormal laboratory test values due to this drug were observed in any of the patients enrolled in this study. From the above results, SBTPC fine granules seem to be useful in the treatment of pediatric and elderly patients who sometimes have difficulties in taking tablets.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
February 1991, The Japanese journal of antibiotics,
M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
December 1988, The Japanese journal of antibiotics,
M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
December 1988, The Japanese journal of antibiotics,
M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
December 1988, The Japanese journal of antibiotics,
M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
December 1988, The Japanese journal of antibiotics,
M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
December 1988, The Japanese journal of antibiotics,
M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
December 1988, The Japanese journal of antibiotics,
M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
December 1988, The Japanese journal of antibiotics,
M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
January 1992, The Journal of international medical research,
M Takamoto, and S Harada, and Y Harada, and Y Kitahara, and T Ishibashi, and A Shinoda
December 1988, The Japanese journal of antibiotics,
Copied contents to your clipboard!